Marissa Brittenham is CSO at Surgery Partners, Inc. (SGRY). They have made 7 open-market trades across 1 company since 2023, most recently 2026-03-13.
CIK 0001908044
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SGRY | 94,196 | $2.2M |
Shares reported on the most recent Form 4, priced at the 2026-03-16 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SGRY | SELL | 2026-03-13 | 2026-03-16 | $12.54 | $46K | -4.4% | +6.5% | +22.1% |
| SGRY | SELL | 2026-03-06 | 2026-03-09 | $13.70 | $120K | -8.7% | -4.2% | +4.8% |
| SGRY | SELL | 2025-03-10 | 2025-03-13 | $24.09 | $152K | +1.2% | -10.8% | -3.1% |
| SGRY | SELL | 2025-02-07 | 2025-02-10 | $25.61 | $376K | -0.9% | -8.3% | -8.9% |
| SGRY | SELL | 2024-03-04 | 2024-03-06 | $30.17 | $39K | -10.8% | -11.1% | -16.4% |
| SGRY | SELL | 2024-02-02 | 2024-02-06 | $31.89 | $104K | +5.2% | -7.8% | -21.4% |
| SGRY | SELL | 2023-02-02 | 2023-02-06 | $35.90 | $47K | +3.7% | -2.0% | +3.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.